Anzeige
Mehr »
Donnerstag, 26.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DZZN | ISIN: US2214133058 | Ticker-Symbol: V67A
Tradegate
25.06.25 | 13:03
0,389 Euro
+4,86 % +0,018
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
COSMOS HEALTH INC Chart 1 Jahr
5-Tage-Chart
COSMOS HEALTH INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,3660,37711:38

Aktuelle News zur COSMOS HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiCosmos Health begins US manufacturing with DolCas Biotech3
COSMOS HEALTH Aktie jetzt für 0€ handeln
DiCosmos Health startet US-Produktion mit DolCas Biotech3
DiCosmos Health Inc.: Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech231CHICAGO, June 24, 2025, a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...
► Artikel lesen
03.06.Cosmos Health Inc. - S-1/A, General form for registration of securities2
15.05.Cosmos Health Inc.: RETRANSMISSION - Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven891CHICAGO, May 15, 2025, a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...
► Artikel lesen
15.05.Cosmos Health Inc.: Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven324CHICAGO, May 15, 2025, a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...
► Artikel lesen
15.05.Cosmos Health Inc. - 10-Q, Quarterly Report2
07.05.Cosmos Health Inc.: Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units326CHICAGO, May 07, 2025, a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...
► Artikel lesen
07.05.Cosmos Health Inc. - 8-K, Current Report2
06.05.Cosmos Health erhält NASDAQ-Fristverlängerung für Compliance-
06.05.Cosmos Health granted Nasdaq compliance extension1
06.05.Cosmos Health Inc.: Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq278CHICAGO, May 06, 2025, a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...
► Artikel lesen
30.04.Cosmos Health CEO boosts stake with $526,000 share purchase1
30.04.Cosmos Health CEO erhöht Beteiligung durch Aktienkauf im Wert von 526.000 US-Dollar2
30.04.Cosmos Health Inc.: Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000316CHICAGO, April 30, 2025, a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...
► Artikel lesen
16.04.Cosmos Health Inc.: Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million319CHICAGO, April 16, 2025, a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...
► Artikel lesen
15.04.Cosmos Health Inc. - 10-K, Annual Report1
09.04.Cosmos Health sichert Vertrag für Antiseptika-Produktion1
09.04.Cosmos Health secures deal for antiseptic drug production2
09.04.Cosmos Health Inc.: Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L427CHICAGO, April 09, 2025 ("Cosmos Health" or the "Company') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical...
► Artikel lesen
Weiter >>
85 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1